Expert Consultations: Real-World Answers

Exploring the Clinical Implications of Broad Spectrum Micronutrient Treatment – Interview

Published on May 1, 2024 Certification expiration date: May 1, 2027

Guest

Wegdan Rashad

To unlock this audio you need to become a Silver, Gold, Silver extended or Gold extended Member.

Check Our CME Program

Downloads for Offline Access

Download Audio File (MP3)

Interview Highlights

Ideal candidates for BSMs include those with emotional dysregulation, a history of inadequate response to psychotropic medication, younger patients, and individuals motivated to adhere to the supplementation regimen. The patient's dietary habits, lifestyle, and gastrointestinal health should also be considered.
Side effects of BSMs include transient headaches, insomnia, GI side effects, and worsening of a pre-existing GI dysfunction.

Text Version

Dr. Rashad: Greetings to all. You're tuned into Expert Consultations with the Psychopharmacology Institute. I am Dr. Wegdan Rashad, and today, we are delving into the realm of broad-spectrum micronutrients (BSMs) with Dr. Amelia Villagomez. Dr. Villagomez, renowned for her role as a child and adolescent psychiatrist and as Co-Director of the Integrative Psychiatry Program at the University of Arizona, has previously provided an insightful 2-part lecture

Unlock this Expert Consultation and earn 0.75 CMEs
Become a Silver, Gold, Silver extended or Gold extended Member.

Get Instant Access

Already have an account? Sign in

Learning Objectives:

After completing this activity, the learner will be able to:

Identify the key components and criteria of broad-spectrum micronutrients (BSMs) as used in psychiatric treatment
Evaluate the clinical relevance and application of BSMs in managing conditions like ADHD, based on current research and expert opinions shared during the interview
Discuss the potential interactions of BSMs with other medication and the importance of diligent patient monitoring and tailored treatment plans in integrative psychiatry

Original Release Date: May 1, 2024

Expiration Date: May 1, 2027

Expert: Amelia Villagomez, M.D.

Medical Editors: Wegdan Rashad, M.D., Melissa Mariano, M.D.

Relevant Financial Disclosures:

None of the faculty, planners, and reviewers for this educational activity have relevant financial relationships to disclose during the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com

Instructions for Participation and Credit:

Participants must complete the activity online during the valid credit period that is noted above.

Follow these steps to earn CME credit:

View the required educational content provided on this course page.
Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credits.
Download your certificate.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

Medical Academy designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Amelia Villagomez, M.D.